Assembly Biosciences Q2 EPS $(0.32) Misses $(0.29) Estimate
Portfolio Pulse from Benzinga Newsdesk
Assembly Biosciences reported Q2 losses of $0.32 per share, missing the analyst consensus estimate of $0.29 by 10.34%. However, this is a 37.25% increase over losses of $0.51 per share from the same period last year.
August 09, 2023 | 9:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Assembly Biosciences' Q2 earnings per share of $0.32 missed estimates by 10.34%, but showed a 37.25% improvement YoY.
Assembly Biosciences' Q2 earnings missed analyst estimates, which could negatively impact the stock price in the short term. However, the YoY improvement in losses might mitigate this impact to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100